• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎的生物治疗方法。

Biotherapeutic Approaches in Atopic Dermatitis.

机构信息

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.

Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, 119074, Singapore.

出版信息

Biotechnol J. 2020 Oct;15(10):e1900322. doi: 10.1002/biot.201900322. Epub 2020 Apr 6.

DOI:10.1002/biot.201900322
PMID:32176834
Abstract

The skin microbiome plays a central role in inflammatory skin disorders such as atopic dermatitis (AD). In AD patients, an imbalance between pathogenic Staphylococcus aureus (S. aureus) and resident skin symbionts creates a state of dysbiosis which induces immune dysregulation and impairs skin barrier function. There are now exciting new prospects for microbiome-based interventions for AD prevention. In the hopes of achieving sustained control and management of disease in AD patients, current emerging biotherapeutic strategies aim to harness the skin microbiome associated with health by restoring a more diverse symbiotic skin microbiome, while selectively removing pathogenic S. aureus. Examples of such strategies are demonstrated in skin microbiome transplants, phage-derived anti-S. aureus endolysins, monoclonal antibodies, and quorum sensing (QS) inhibitors. However, further understanding of the skin microbiome and its role in AD pathogenesis is still needed to understand how these biotherapeutics alter the dynamics of the microbiome community; to optimize patient selection, drug delivery, and treatment duration; overcome rapid recolonization upon treatment cessation; and improve efficacy to allow these therapeutic options to eventually reach routine clinical practice.

摘要

皮肤微生物组在炎症性皮肤疾病(如特应性皮炎)中起着核心作用。在 AD 患者中,致病性金黄色葡萄球菌(S. aureus)和常驻皮肤共生体之间的失衡会导致微生态失调,从而诱导免疫失调和破坏皮肤屏障功能。目前,基于微生物组的 AD 预防干预措施具有令人兴奋的新前景。为了实现对 AD 患者疾病的持续控制和管理,当前新兴的生物治疗策略旨在通过恢复更具多样性的共生皮肤微生物组,同时选择性地去除致病性 S. aureus,利用与健康相关的皮肤微生物组。此类策略的示例包括皮肤微生物组移植、噬菌体衍生的抗 S. aureus 内溶素、单克隆抗体和群体感应(QS)抑制剂。然而,为了了解这些生物疗法如何改变微生物组群落的动态,仍需要进一步了解皮肤微生物组及其在 AD 发病机制中的作用;优化患者选择、药物输送和治疗持续时间;克服治疗停止后的快速再定植;并提高疗效,以使这些治疗选择最终能够常规应用于临床实践。

相似文献

1
Biotherapeutic Approaches in Atopic Dermatitis.特应性皮炎的生物治疗方法。
Biotechnol J. 2020 Oct;15(10):e1900322. doi: 10.1002/biot.201900322. Epub 2020 Apr 6.
2
Skin microbiome of atopic dermatitis.特应性皮炎的皮肤微生物组。
Allergol Int. 2022 Jan;71(1):31-39. doi: 10.1016/j.alit.2021.11.001. Epub 2021 Nov 24.
3
Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review.皮肤微生物组失调与金黄色葡萄球菌在成人和儿童特应性皮炎中的作用:叙述性综述。
J Eur Acad Dermatol Venereol. 2023 Jun;37 Suppl 5:3-17. doi: 10.1111/jdv.19125.
4
Effect of Staphylococcus aureus colonization and immune defects on the pathogenesis of atopic dermatitis.金黄色葡萄球菌定植和免疫缺陷对特应性皮炎发病机制的影响。
Arch Microbiol. 2024 Sep 20;206(10):410. doi: 10.1007/s00203-024-04134-w.
5
The role of the skin microbiome in atopic dermatitis - correlations and consequences.皮肤微生物组在特应性皮炎中的作用——相关性和后果。
J Dtsch Dermatol Ges. 2022 May;20(5):571-577. doi: 10.1111/ddg.14709. Epub 2022 Apr 5.
6
Pathogenic role of the staphylococcal accessory gene regulator quorum sensing system in atopic dermatitis.金黄色葡萄球菌附属基因调控器群体感应系统在特应性皮炎中的致病作用。
Front Cell Infect Microbiol. 2023 Apr 14;13:1178650. doi: 10.3389/fcimb.2023.1178650. eCollection 2023.
7
Turning the inside out: the microbiology of atopic dermatitis.内外翻转:特应性皮炎的微生物组学。
Environ Microbiol. 2016 Jul;18(7):2089-102. doi: 10.1111/1462-2920.13050. Epub 2015 Dec 4.
8
Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification.探索特应性皮炎发病机制和疾病修饰中的皮肤微生物组。
J Allergy Clin Immunol. 2024 Jul;154(1):31-41. doi: 10.1016/j.jaci.2024.04.029. Epub 2024 May 16.
9
[Atopic eczema and microbiome].[特应性皮炎与微生物群]
Hautarzt. 2019 Jun;70(6):407-415. doi: 10.1007/s00105-019-4424-6.
10
The microbiome in patients with atopic dermatitis.特应性皮炎患者的微生物组。
J Allergy Clin Immunol. 2019 Jan;143(1):26-35. doi: 10.1016/j.jaci.2018.11.015. Epub 2018 Nov 23.

引用本文的文献

1
Disease modification in inflammatory skin disorders: opportunities and challenges.炎症性皮肤疾病的疾病修饰:机遇与挑战。
Nat Rev Drug Discov. 2023 Aug;22(8):662-680. doi: 10.1038/s41573-023-00735-0. Epub 2023 Jul 13.
2
Future trends in synthetic biology in Asia.亚洲合成生物学的未来趋势。
Adv Genet (Hoboken). 2021 Mar 5;2(1):e10038. doi: 10.1002/ggn2.10038. eCollection 2021 Mar.
3
Living symbiotic bacteria-involved skin dressing to combat indigenous pathogens for microbiome-based biotherapy toward atopic dermatitis.
用于对抗本土病原体的含活共生细菌的皮肤敷料,用于基于微生物群的特应性皮炎生物疗法。
Bioact Mater. 2022 Sep 12;21:253-266. doi: 10.1016/j.bioactmat.2022.08.019. eCollection 2023 Mar.
4
Model-Based Meta-Analysis to Optimize ‒Targeted Therapies for Atopic Dermatitis.基于模型的荟萃分析以优化特应性皮炎的靶向治疗
JID Innov. 2022 Feb 18;2(3):100110. doi: 10.1016/j.xjidi.2022.100110. eCollection 2022 May.
5
Microbial manipulation in atopic dermatitis.特应性皮炎中的微生物调控
Clin Transl Med. 2022 Apr;12(4):e828. doi: 10.1002/ctm2.828.
6
The emerging potential of microbiome transplantation on human health interventions.微生物群移植在人类健康干预方面的新兴潜力。
Comput Struct Biotechnol J. 2022 Jan 19;20:615-627. doi: 10.1016/j.csbj.2022.01.009. eCollection 2022.
7
Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus.特应性皮炎的微生物组皮肤微生态失调具有特定部位特征,涉及细菌、真菌和病毒。
BMC Microbiol. 2021 Sep 23;21(1):256. doi: 10.1186/s12866-021-02302-2.
8
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.特应性皮炎:复杂疾病的治疗领域不断拓展。
Nat Rev Drug Discov. 2022 Jan;21(1):21-40. doi: 10.1038/s41573-021-00266-6. Epub 2021 Aug 20.
9
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy?特应性皮炎作为一种多因素皮肤疾病。对病理生理靶点的分析能否代表成功的治疗策略?
Pharmaceuticals (Basel). 2020 Nov 22;13(11):411. doi: 10.3390/ph13110411.